In this study, we have firstly demonstrated that either GSK‐3α or GSK‐3β is highly expressed in both the CRSsNP and normal nasal mucosa, indicating that GSK‐3 may be involved in the inflammatory response in CRSsNP patients. This evidence concerns the gene GSK3B and chronic rhinosinusitis without nasal polyps.